Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10909366 | 0.85 | PPARG (0.54) | PPARAPPARGTAAR1CYP1A2CTBP2 | |
| SCHEMBL1368547 | 0.84 | TAAR1 (0.58) | PPARATAAR1CYP1A2CTBP2MEN1 | |
| SCHEMBL28019828 | 0.84 | TAAR1 (0.58) | PPARATAAR1CYP1A2CTBP2MEN1 | |
| SCHEMBL8953537 | 0.84 | TAAR1 (0.58) | PPARATAAR1CYP1A2CTBP2MEN1 | |
| SCHEMBL7511969 | 0.84 | TAAR1 (0.58) | PPARATAAR1CYP1A2CTBP2MEN1 | |
| SCHEMBL4594693 | 0.83 | TAAR1 (0.57) | TAAR1MEN1KMT2AHIF1A | |
| SCHEMBL28020294 | 0.83 | TAAR1 (0.57) | TAAR1MEN1KMT2AHIF1A | |
| SCHEMBL352986 | 0.81 | SRR (0.59) | PPARAPPARGACE | |
| SCHEMBL28278431 | 0.81 | SRR (0.59) | PPARAPPARGACE | |
| SCHEMBL8953478 | 0.81 | PPARG (0.57) | PPARAPPARGACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5514773-A | PARASITICIDES, ANTHELMINTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-07 | — | — | US | disclosed |